2.70
+0.14(+5.48%)
Currency In USD
| Previous Close | 2.56 |
| Open | 2.54 |
| Day High | 2.75 |
| Day Low | 2.52 |
| 52-Week High | 5.39 |
| 52-Week Low | 1.6 |
| Volume | 1.48M |
| Average Volume | 1.56M |
| Market Cap | 200.3M |
| PE | -1.78 |
| EPS | -1.51 |
| Moving Average 50 Days | 2.89 |
| Moving Average 200 Days | 3.01 |
| Change | 0.14 |
If you invested $1000 in Perspective Therapeutics, Inc. (CATX) 10 years ago, it would be worth $254.25 as of December 12, 2025 at a share price of $2.695. Whereas If you bought $1000 worth of Perspective Therapeutics, Inc. (CATX) shares 5 years ago, it would be worth $655.72 as of December 12, 2025 at a share price of $2.695.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the ASCO Gastrointestinal Cancers Symposium
GlobeNewswire Inc.
Dec 04, 2025 12:00 PM GMT
SEATTLE, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announ
Perspective Therapeutics to Participate in Upcoming December Conferences
GlobeNewswire Inc.
Nov 20, 2025 12:00 PM GMT
SEATTLE, Nov. 20, 2025 (GLOBE NEWSWIRE) -- November 20, 2025 – Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout t
Perspective Therapeutics to Participate in Upcoming November Conferences
GlobeNewswire Inc.
Oct 31, 2025 11:00 AM GMT
SEATTLE, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announ